FibroBiologics (NASDAQ:FBLG) Receives “Buy” Rating from D. Boral Capital
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at D. Boral Capital in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $16.00 price target on the stock. Several other equities research analysts have also recently weighed in on FBLG. HC Wainwright […]
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at D. Boral Capital in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $16.00 price target on the stock. Several other equities research analysts have also recently weighed in on FBLG. HC Wainwright […]
